DE3100150A1 - Verfahren und vorrichtung zur fraktionierung von proteingemischen - Google Patents
Verfahren und vorrichtung zur fraktionierung von proteingemischenInfo
- Publication number
- DE3100150A1 DE3100150A1 DE19813100150 DE3100150A DE3100150A1 DE 3100150 A1 DE3100150 A1 DE 3100150A1 DE 19813100150 DE19813100150 DE 19813100150 DE 3100150 A DE3100150 A DE 3100150A DE 3100150 A1 DE3100150 A1 DE 3100150A1
- Authority
- DE
- Germany
- Prior art keywords
- protein
- dilution
- salt
- plasma
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000004169 proteins and genes Human genes 0.000 title claims description 40
- 108090000623 proteins and genes Proteins 0.000 title claims description 40
- 238000000034 method Methods 0.000 title claims description 34
- 239000000203 mixture Substances 0.000 title claims description 29
- 238000005194 fractionation Methods 0.000 title claims description 7
- 150000003839 salts Chemical class 0.000 claims description 45
- 210000002381 plasma Anatomy 0.000 claims description 39
- 235000018102 proteins Nutrition 0.000 claims description 39
- 238000000909 electrodialysis Methods 0.000 claims description 25
- 238000010790 dilution Methods 0.000 claims description 21
- 239000012895 dilution Substances 0.000 claims description 21
- 102000005686 Serum Globulins Human genes 0.000 claims description 9
- 108010045362 Serum Globulins Proteins 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 210000004369 blood Anatomy 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 235000004252 protein component Nutrition 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 210000002966 serum Anatomy 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 3
- 102000006395 Globulins Human genes 0.000 claims description 2
- 108010044091 Globulins Proteins 0.000 claims description 2
- 150000001450 anions Chemical class 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims 3
- 239000003146 anticoagulant agent Substances 0.000 claims 2
- 229940127219 anticoagulant drug Drugs 0.000 claims 2
- 210000000601 blood cell Anatomy 0.000 claims 2
- 150000001768 cations Chemical class 0.000 claims 2
- 238000005868 electrolysis reaction Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 239000003792 electrolyte Substances 0.000 description 7
- 102000009027 Albumins Human genes 0.000 description 6
- 108010088751 Albumins Proteins 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- 238000010612 desalination reaction Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000002616 plasmapheresis Methods 0.000 description 5
- 238000011065 in-situ storage Methods 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 229960002897 heparin Drugs 0.000 description 3
- 229920000669 heparin Polymers 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000008151 electrolyte solution Substances 0.000 description 2
- 229940021013 electrolyte solution Drugs 0.000 description 2
- 239000004023 fresh frozen plasma Substances 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011833 salt mixture Substances 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 102000006734 Beta-Globulins Human genes 0.000 description 1
- 108010087504 Beta-Globulins Proteins 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010053614 Type III immune complex mediated reaction Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- -1 blood sugar Chemical class 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 230000002134 immunopathologic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003014 ion exchange membrane Substances 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000009979 protective mechanism Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/42—Electrodialysis; Electro-osmosis ; Electro-ultrafiltration; Membrane capacitive deionization
- B01D61/44—Ion-selective electrodialysis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/144—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by electrical means, e.g. electrodialysis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A61M1/3482—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate by filtrating the filtrate using another cross-flow filter, e.g. a membrane filter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/42—Electrodialysis; Electro-osmosis ; Electro-ultrafiltration; Membrane capacitive deionization
- B01D61/44—Ion-selective electrodialysis
- B01D61/46—Apparatus therefor
- B01D61/463—Apparatus therefor comprising the membrane sequence AC or CA, where C is a cation exchange membrane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2321/00—Details relating to membrane cleaning, regeneration, sterilization or to the prevention of fouling
- B01D2321/22—Electrical effects
- B01D2321/223—Polarity reversal
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
- Y10S530/83—Plasma; serum
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Water Supply & Treatment (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Water Treatment By Electricity Or Magnetism (AREA)
- Peptides Or Proteins (AREA)
- External Artificial Organs (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/111,144 US4276140A (en) | 1980-01-10 | 1980-01-10 | Electrodialysis apparatus and process for fractionating protein mixtures |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE3100150A1 true DE3100150A1 (de) | 1981-11-19 |
Family
ID=22336846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19813100150 Withdrawn DE3100150A1 (de) | 1980-01-10 | 1981-01-07 | Verfahren und vorrichtung zur fraktionierung von proteingemischen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4276140A (en]) |
| JP (1) | JPS56100720A (en]) |
| CA (1) | CA1149328A (en]) |
| DE (1) | DE3100150A1 (en]) |
| FR (1) | FR2473337A1 (en]) |
| GB (1) | GB2067594B (en]) |
| IT (1) | IT1142208B (en]) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3147377A1 (de) * | 1981-11-30 | 1983-06-01 | Akzo Gmbh, 5600 Wuppertal | Verfahren und vorrichtung zur extrakorporalen entfernung von an eiweisskoerpern gebundenen toxinen |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4426323A (en) | 1980-01-10 | 1984-01-17 | Ionics, Incorporated | Selected recovery of proteins from fermentation broths |
| US4437968A (en) | 1980-09-10 | 1984-03-20 | Zerpol Corporation | Boiler apparatus |
| WO1982002841A1 (en) * | 1981-02-18 | 1982-09-02 | University Patents Inc | Precipitation of proteins |
| US4435318A (en) | 1981-05-22 | 1984-03-06 | Ionics, Incorporated | Electrodialysis preparation of purified AHF concentrate |
| US4441978A (en) * | 1981-06-29 | 1984-04-10 | Ionics Incorporated | Separation of proteins using electrodialysis - isoelectric focusing combination |
| FR2520235A1 (fr) * | 1982-01-27 | 1983-07-29 | Bel Fromageries | Procede de separation d'immunoglobulines a partir de colostrum |
| DE3219248A1 (de) * | 1982-05-21 | 1983-11-24 | Solco Basel AG, Birsfelden | Verfahren zur gewinnung zellatmungsfoerdernder wirkstoffe aus kaelberblut |
| US4486282A (en) * | 1983-02-22 | 1984-12-04 | University Patents, Inc. | Precipitation of proteins from salt-containing proteinaceous fluids employing a desalting treatment, and use thereof in selective plasmapheresis |
| SE8402861L (sv) * | 1984-05-28 | 1985-11-29 | Stefan Svenson | Rening av biologiskt material |
| US4938856A (en) * | 1989-03-01 | 1990-07-03 | Fmc Corporation | Process for mild heat treatment of a flowable fluid |
| US5437774A (en) * | 1993-12-30 | 1995-08-01 | Zymogenetics, Inc. | High molecular weight electrodialysis |
| AUPP521298A0 (en) * | 1998-08-12 | 1998-09-03 | Life Therapeutics Limited | Purification of fibrinogen |
| AUPP790898A0 (en) | 1998-12-23 | 1999-01-28 | Life Therapeutics Limited | Renal dialysis |
| US7066900B2 (en) * | 1998-12-23 | 2006-06-27 | Life Therapeutics | Removal of metabolic components from blood |
| AUPP790698A0 (en) * | 1998-12-23 | 1999-01-28 | Life Therapeutics Limited | Separation of microorganisms |
| AUPR748501A0 (en) * | 2001-09-04 | 2001-09-27 | Life Therapeutics Limited | Renal dialysis |
| US20050224355A1 (en) * | 1999-12-23 | 2005-10-13 | Brendon Conlan | Removal of biological contaminants |
| US7077942B1 (en) * | 1999-12-23 | 2006-07-18 | Gradipore Limited | Removal of biological contaminants |
| AUPQ691400A0 (en) * | 2000-04-14 | 2000-05-11 | Life Therapeutics Limited | Separation of micromolecules |
| AUPQ697300A0 (en) | 2000-04-18 | 2000-05-11 | Life Therapeutics Limited | Separation apparatus |
| ATE449200T1 (de) | 2000-04-18 | 2009-12-15 | Gradipore Ltd | Trennung und behandlung von proben durch elektrophorese |
| US6923896B2 (en) * | 2000-09-22 | 2005-08-02 | The Texas A&M University System | Electrophoresis apparatus and method |
| EP1341596B1 (en) * | 2000-10-06 | 2010-07-07 | Arturus Capital Limited | Multi-port electrophoresis separation apparatus and corresponding method |
| AUPR110100A0 (en) * | 2000-10-30 | 2000-11-23 | Life Therapeutics Limited | Improved separation of macromolecules |
| AUPR222300A0 (en) * | 2000-12-21 | 2001-01-25 | Life Therapeutics Limited | Electrophoresis device and method |
| AU2002325669B2 (en) * | 2001-09-04 | 2004-11-11 | Life Therapeutics Limited | Removal of metabolic components from blood |
| US6797299B2 (en) * | 2002-02-05 | 2004-09-28 | Great Wall Enterprise Co., Ltd. | Desalting method for nutritional supplements with animal protein |
| US7959780B2 (en) | 2004-07-26 | 2011-06-14 | Emporia Capital Funding Llc | Textured ion exchange membranes |
| US7780833B2 (en) | 2005-07-26 | 2010-08-24 | John Hawkins | Electrochemical ion exchange with textured membranes and cartridge |
| KR101333243B1 (ko) | 2005-10-06 | 2013-11-26 | 파이오네틱스 코포레이션 | 유체의 전기화학적 이온교환 처리 |
| US8123713B2 (en) * | 2008-08-12 | 2012-02-28 | Caridian Bct, Inc. | System and method for collecting plasma protein fractions from separated blood components |
| US8202240B2 (en) * | 2008-08-12 | 2012-06-19 | Caridianbct, Inc. | System and method for collecting plasma protein fractions from separated blood components |
| ITBO20090437A1 (it) * | 2009-07-07 | 2011-01-08 | Hemodec S R L | Apparecchiatura per il trattamento del sangue |
| US9757695B2 (en) | 2015-01-03 | 2017-09-12 | Pionetics Corporation | Anti-scale electrochemical apparatus with water-splitting ion exchange membrane |
| ES2940192T3 (es) * | 2015-07-07 | 2023-05-04 | Nashwa Khalil | Inmunomodulación mecánica autoinmune |
| US12121642B2 (en) | 2015-07-07 | 2024-10-22 | AMINA Sciences LLC | Autoimmune mechanical immunomodulation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2131859B1 (en]) * | 1971-03-30 | 1974-03-08 | Rhone Poulenc Sa | |
| US3788959A (en) * | 1972-05-05 | 1974-01-29 | Sybron Corp | Electrodialytic recovery of acid and insoluble products from spent liquors |
| US3972791A (en) * | 1974-05-06 | 1976-08-03 | Harold Stern | Fractionation of proteins by electrical means |
| DE2431719A1 (de) * | 1974-07-02 | 1976-01-22 | Behringwerke Ag | Verfahren zur gewinnung von proteinkonjugaten |
| FR2391653A1 (fr) * | 1977-05-23 | 1978-12-22 | Nestle Sa Soc Ass Tech Prod | Procede de traitement du lactoserum |
| US4115225A (en) * | 1977-07-22 | 1978-09-19 | Ionics, Inc. | Electrodialysis cell electrode reversal and anolyte recirculation system |
| US4146455A (en) * | 1978-04-19 | 1979-03-27 | Ionics Inc. | Process for treating whey |
-
1980
- 1980-01-10 US US06/111,144 patent/US4276140A/en not_active Expired - Lifetime
- 1980-11-12 CA CA000364458A patent/CA1149328A/en not_active Expired
- 1980-11-28 FR FR8025363A patent/FR2473337A1/fr active Granted
- 1980-12-18 GB GB8040573A patent/GB2067594B/en not_active Expired
-
1981
- 1981-01-06 IT IT47516/81A patent/IT1142208B/it active
- 1981-01-07 DE DE19813100150 patent/DE3100150A1/de not_active Withdrawn
- 1981-01-10 JP JP164681A patent/JPS56100720A/ja active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3147377A1 (de) * | 1981-11-30 | 1983-06-01 | Akzo Gmbh, 5600 Wuppertal | Verfahren und vorrichtung zur extrakorporalen entfernung von an eiweisskoerpern gebundenen toxinen |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2067594A (en) | 1981-07-30 |
| JPS56100720A (en) | 1981-08-12 |
| FR2473337B1 (en]) | 1983-11-04 |
| GB2067594B (en) | 1983-02-02 |
| IT1142208B (it) | 1986-10-08 |
| US4276140A (en) | 1981-06-30 |
| FR2473337A1 (fr) | 1981-07-17 |
| IT8147516A0 (it) | 1981-01-06 |
| CA1149328A (en) | 1983-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3100150A1 (de) | Verfahren und vorrichtung zur fraktionierung von proteingemischen | |
| DE3586832T2 (de) | Vorrichtung zum abtrennen von blutplasma-eiweiss. | |
| DE3112538A1 (de) | Verfahren zur auftrennung von waessrigen proteingemischen | |
| US4351710A (en) | Fractionation of protein mixtures | |
| DE69023093T2 (de) | Verfahren zur Reinigung von Wasser. | |
| DE60117686T2 (de) | Verfahren und vorrichtung zur abtrennung von ionenarten aus einer flüssigkeit | |
| DE3130770C2 (de) | Verfahren zur Gewinnung von hepatitissicheren, sterilen, pyrogenfreien und stromafreien Hämoglobinlösungen | |
| DE3881217T2 (de) | Extraktionsverfahren reiner fraktionen von laktoperoxidase und laktoferrin aus milchserum. | |
| DE3112539A1 (de) | Verfahren zur auftrennung von waessrigen proteingemischen | |
| EP0156961B1 (de) | Verfahren zur Herstellung hochgereinigter, stromafreier, hepatitissicherer Human- und Tierhämoglobinlösungen | |
| DE69203828T2 (de) | Verfahren zur behandlung von produkten roter blutkörperchen zur langzeitlagerung frei von mikroorganismen. | |
| DE69114158T2 (de) | Immunoglobulin G und Verfahren zu seiner Herstellung. | |
| DE3310727A1 (de) | Verfahren und vorrichtung zur selektiven, extrakorporalen abtrennung pathologischer und/oder toxischer blutbestandteile | |
| EP3599226B1 (de) | Verfahren und vorrichtung zur anreicherung von silikat in trinkwasser | |
| DE2215761A1 (de) | Verfahren und Vorrichtung für die Zwangsstrom-Elektrophorese | |
| DE2519909A1 (de) | Verfahren zum fraktionieren fluessiger loesungen von proteingemischen | |
| US4146455A (en) | Process for treating whey | |
| EP0113447B1 (de) | Verfahren zur fraktionierten Auftrennung von Proteingemischen mittels Membranen | |
| DE3686390T2 (de) | Verfahren zur herstellung vom antihaemophilfaktor (ahf) durch kaeltefaellung und zur verbesserung der loeslichkeit des hergestellten ahf-produktes. | |
| DE69729619T2 (de) | Entmineralisierung von Käserei-Süssmolke | |
| US4180451A (en) | Apparatus for treating whey | |
| DE69507613T2 (de) | Verfahren zur fraktionierung von molkebestandteilen | |
| DE3219248A1 (de) | Verfahren zur gewinnung zellatmungsfoerdernder wirkstoffe aus kaelberblut | |
| DE69514651T2 (de) | Verfahren zur demineralisierung einer flüssigkeit, die lösungen von organischen substanzen und salzen enthält | |
| DE1963101A1 (de) | Verfahren zur Rueckgewinnung von Saeuren und Metallen durch Elektrodialyse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8141 | Disposal/no request for examination |